Patents-Review.com
ClassID:

20562 ⎘

A61K31/745 - CPC Classification

Classification description:

Medicinal preparations containing organic active ingredients; Synthetic polymeric materials Polymers of hydrocarbons

Sub-classes:
Recent Application in this class:
#1
20260053929
2026-02-26

METAL CHELATING COMPOSITIONS AND METHODS FOR CONTROLLING THE GROWTH OR ACTIVITIES OF A LIVING CELL OR ORGANISM

 #2
20250387449
2025-12-25

PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER

 #3
20250281521
2025-09-11

COMPOSITIONS FOR THE TREATMENT OF DRY EYE

 #4
20240277755
2024-08-22

Hypertension Preload Treatment and Method

 #5
20240122963
2024-04-18

COMPOSITIONS FOR THE TREATMENT OF DRY EYE

 #6
20240082817
2024-03-14

Use Of A Hemocompatible Porous Polymer Bead Sorbent For Removal Of Endotoxemia-Inducing Molecules

 #7
20230330176
2023-10-19

PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER

 #8
20220202850
2022-06-30

METHOD OF INDUCING SATIETY

 #9
20220125829
2022-04-28

METHODS AND COMPOSITIONS FOR TREATING MEIBOMIAN GLAND DYSFUNCTION, DRY EYE DISEASE, AND RELATED DISORDERS

 #10
20220096523
2022-03-31

COMPOSITIONS FOR THE TREATMENT OF DRY EYE

 #11
20220032267
2022-02-03

Use of a hemocompatible porous polymer bead sorbent for removal of endotoxemia-inducing molecules

 #12
20210330697
2021-10-28

Method Of Treating Inflammation

 #13
20210290661
2021-09-23

IMMUNE MODIFYING PARTICLES FOR THE TREATMENT OF CANCER

 #14
20210030827
2021-02-04

Treatment of dermatological conditions

 #15
20210000859
2021-01-07

COMPOSITIONS FOR THE TREATMENT OF DRY EYE

 #16
20200330545
2020-10-22

PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER

 #17
20200330510
2020-10-22

Resurrection of antibiotics that MRSA resists by silver-doped bioactive glass-ceramic particles

 #18
20200297848
2020-09-24

METAL CHELATING COMPOSITIONS AND METHODS FOR CONTROLLING THE GROWTH OR ACTIVITIES OF A LIVING CELL OR ORGANISM

 #19
20200155569
2020-05-21

Compositions comprising triterpenoids

 #20
20190314389
2019-10-17

Compositions comprising triterpenoids

 #21
20190282608
2019-09-19

Method of treating inflammation

 #22
20190275122
2019-09-12

PHARMACEUTICAL COMPOSITIONS OF LIPASE-CONTAINING PRODUCTS, IN PARTICULAR OF PANCREATIN

 #23
20190247419
2019-08-15

COMPOSITIONS FOR THE TREATMENT OF DRY EYE

 #24
20190209582
2019-07-11

Compositions comprising triterpenoids

 #25
20190201867
2019-07-04

Use of a hemocompatible porous polymer bead sorbent for removal of endotoxemia-inducing molecules

 #26
20190192594
2019-06-27

THERAPEUTIC USES OF MASTIC GUM FRACTIONS

 #27
20190046451
2019-02-14

CHOLESTYRAMINE PELLETS, ORAL CHOLESTYRAMINE FORMULATIONS AND USE THEREOF

 #28
20180360871
2018-12-20

Oral cholestyramine formulation and use thereof

 #29
20180360870
2018-12-20

Oral cholestyramine formulation and use thereof

 #30
20180360869
2018-12-20

Oral cholestyramine formulation and use thereof

 #31
20180311273
2018-11-01

Method of treating inflammation

 #32
20180264118
2018-09-20

Hydrogel formulation with mild adhesion

 #33
20180264031
2018-09-20

CHOLESTYRAMINE PELLETS AND METHODS FOR PREPARATION THEREOF

 #34
20180264030
2018-09-20

Cholestyramine pellets and methods for preparation thereof

 #35
20180264029
2018-09-20

Oral cholestyramine formulation and use thereof

 #36
20180264006
2018-09-20

Compositions comprising triterpenoids

 #37
20180154050
2018-06-07

Reduction of implant infection via tunable stimulation of localized adaptive immune response

 #38
20180064751
2018-03-08

COMPOSITIONS AND METHODS FOR TREATING HYPERKALEMIA

 #39
20170296574
2017-10-19

Method of treating inflammation

 #40
20170273888
2017-09-28

Biodegradable microspheres

 #41
20170258824
2017-09-14

Method of inducing satiety

 #42
20170224721
2017-08-10

Oral cholestyramine formulation and use thereof

 #43
20170224720
2017-08-10

Oral cholestyramine formulation and use thereof

 #44
20170224719
2017-08-10

Cholestyramine pellets and methods for preparation thereof

 #45
20170182115
2017-06-29

PHARMACEUTICAL COMBINATION COMPRISING AN IBAT INHIBITOR AND A BILE ACID BINDER

 #46
20160346318
2016-12-01

Compositions and methods for treating hyperkalemia

 #47
20160324969
2016-11-10

Hydrogel formulation with mild adhesion

 #48
20160287654
2016-10-06

Therapeutic uses of mastic gum fractions

 #49
20160279163
2016-09-29

Method of treating inflammation

 #50
20160038604
2016-02-11

Metal chelating compositions and methods for controlling the growth or activities of a living cell or organism

 #51
20150328387
2015-11-19

Extracorporeal perfusion apparatus

 #52
20150231170
2015-08-20

Wound healing compositions comprising microspheres

 #53
20150196582
2015-07-16

Compositions for the treatment of dry eye

 #54
20150164785
2015-06-18

DEVICES AND METHODS FOR TREATING THE GASTROINTESTINAL SYSTEM

 #55
20150125505
2015-05-07

Reduction of implant infection via tunable stimulation of localized adaptive immune response

 #56
20150110902
2015-04-23

Therapeutic uses of mastic gum fractions

 #57
20150079021
2015-03-19

THERAPEUTIC USES OF OLIGOMERIC AND POLYMERIC MONOTERPENES

 #58
20150024017
2015-01-22

COMPOSITIONS AND METHODS FOR CELL KILLING

 #59
20140242022
2014-08-28

COMPOSITIONS FOR THE TREATEMENT OF DRY EYE

 #60
20140186290
2014-07-03

NANOPARTICLE BASED THERAPY FOR DISPERSING MUCIN

 #61
20140017309
2014-01-16

Enteral administration of sorbent polymer for treatment and prophylaxis of inflammation

 #62
20130287688
2013-10-31

NOVEL COMPOSITIONS AND USES OF ANTI-HYPERTENSION AGENTS FOR CANCER THERAPY

 #63
20130236545
2013-09-12

Pharmaceutical composition comprising citrate and bicarbonate salts, and use thereof for treating cystinuria

 #64
20130195792
2013-08-01

Method of treating inflammation

 #65
20130129975
2013-05-23

MEDICAL OR BIOCHEMICAL RESIN COMPOSITION AND RESIN MOLDED PRODUCT

 #66
20130090308
2013-04-11

Compositions for the treatment of dry eye

 #67
20120220659
2012-08-30

Medicament having promoting action on hepatocyte proliferation

 #68
20120213727
2012-08-23

THERAPEUTIC USES OF OLIGOMERIC AND POLYMERIC MONOTERPENES

 #69
20120027814
2012-02-02

Polymeric fibers having tissue reactive members

 #70
20120003175
2012-01-05

Therapeutic uses of mastic gum fractions

 #71
20110223128
2011-09-15

Regulation of microvasculature occlusion

 #72
20110217379
2011-09-08

MAGNETIC NANOMATERIALS AND METHODS FOR CHEMOEMBOLISATION

 #73
20110212172
2011-09-01

Administration of an adsorbent polymer for treatment of systemic inflammation

 #74
20110135744
2011-06-09

Nanoparticle Based Therapy for Dispersing Mucin

 #75
20100272768
2010-10-28

Compositions and methods for cell killing

 #76
20100184859
2010-07-22

MEDICAMENT HAVING PROMOTING ACTION ON HEPATOCYTE PROLIFERATION

 #77
20100178327
2010-07-15

Active ingredient of a medicinal agent, a medicinal agent, a pharmaceutical composition and method for treating dementia syndrome patients

 #78
20090036531
2009-02-05

Method for treatment of onychomycosis

 #79
20080233076
2008-09-25

Process for stabilizing ascorbic acid compositions

 #80
20070274935
2007-11-29

Method for treatment of onychomycosis

 #81
20060275334
2006-12-07

Parasiticidal composition

 #82
20060240096
2006-10-26

Devices and methods for treating the gastrointestinal system

 #83
20050250817
2005-11-10

Pharmaceutical compositions of lipase-containing products, in particular of pancreation

 #84
20050013791
2005-01-20

Cytokine-inducing material and cytokine-inducing instrument

 #85
15226349
2017-09-19

Composition and method for treating skin conditions